Photys
Randall Morin currently serves as the Head of Corporate Operations and General Counsel at Photys Therapeutics, a position held since 2022. Prior to this role, Randall was the Global Head of Legal for Vaccines R&D and Medicines at Sanofi and held senior legal positions at Translate Bio, Vertex Pharmaceuticals, and Shire, where responsibilities included leading intellectual property and business development transactions. Early career experience includes roles at Morin IP Law, Goodwin Procter LLP, Testa, Hurwitz & Thibeault, LLP, and Wyeth Biopharma. Academic credentials include an MBA from Babson F.W. Olin Graduate School of Business, a JD from Boston University School of Law (cum laude), a Master of Science in Biotechnology Engineering from Tufts University, and a Bachelor of Arts in Biology from Saint Anselm College, with minors in Philosophy and Classics.
This person is not in any teams
This person is not in any offices
Photys
3 followers
Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein post-translational modifications, going beyond degradation to restore protein function, repair signaling, and amplify endogenous disease-fighting mechanisms. Photys was co-founded by the Broad Institute’s leading bifunctional chemist, Amit Choudhary, and the Longwood Fund, alongside a scientific advisory board comprised of distinguished scientists and drug developers – MIT’s Angela Koehler, Salk’s Tony Hunter, Berkeley’s Dan Nomura, MPM’s Wendy Young, and Dana Farber’s Eric Fischer.
Employees
11-50